Michael Montalto, Amgen | How to have the biggest impact on patients: a career of invention, innovation, and implementation

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/7a/89/d2/7a89d2eb-58c2-8887-e394-e727c76dc72f/mza_5501671720659720569.jpg/600x600bb.jpg

Talking Precision Medicine

Genialis

51 episodes

4 days ago

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.

Life Sciences

Science

RSS

All content for Talking Precision Medicine is the property of Genialis and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/1109085/1109085-1591869612639-da4fed0a60a7.jpg

Michael Montalto, Amgen | How to have the biggest impact on patients: a career of invention, innovation, and implementation | TPM podcast #48

Talking Precision Medicine

43 minutes 24 seconds

3 months ago

Michael Montalto, Amgen | How to have the biggest impact on patients: a career of invention, innovation, and implementation | TPM podcast #48

Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical companies in translating research and development into approved therapies. A key part of that success comes from their focus on precision medicine, and Mike brings a unique perspective from the forefront of that work.

⁠⁠TPM E48 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠

Episode 48 links: